Multimedia

Developing Viral Vaccines for Emerging Infectious Diseases

Developing Viral Vaccines for Emerging Infectious Diseases

Innovative new technologies support and accelerate vaccine discovery to help combat new and emerging pathogens

The recent global outbreak of a novel pandemic COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reminds us of the constant need for continued vaccine development as viral threats evolve. Unprecedented efforts and collaborations in the scientific community are underway to develop a vaccine. 

See how Sartorius’ innovative solutions advance and accelerate discovery and development of new vaccines against viral infections!

Access this free infographic, compliments of Sartorius.